nodes	percent_of_prediction	percent_of_DWPC	metapath
Glipizide—PPARG—systemic lupus erythematosus	0.565	1	CbGaD
Glipizide—CYP2C9—Leflunomide—systemic lupus erythematosus	0.0446	0.174	CbGbCtD
Glipizide—CYP2C9—Dapsone—systemic lupus erythematosus	0.0318	0.124	CbGbCtD
Glipizide—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.0212	0.0827	CbGbCtD
Glipizide—CYP2C9—Cyclosporine—systemic lupus erythematosus	0.0209	0.0816	CbGbCtD
Glipizide—CYP3A4—Dapsone—systemic lupus erythematosus	0.0185	0.0722	CbGbCtD
Glipizide—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.016	0.0626	CbGbCtD
Glipizide—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.016	0.0626	CbGbCtD
Glipizide—CYP2C9—Dexamethasone—systemic lupus erythematosus	0.0138	0.0538	CbGbCtD
Glipizide—CYP3A4—Betamethasone—systemic lupus erythematosus	0.0138	0.0537	CbGbCtD
Glipizide—CYP2C9—cardial valve—systemic lupus erythematosus	0.0137	0.296	CbGeAlD
Glipizide—CYP3A4—Prednisolone—systemic lupus erythematosus	0.0136	0.053	CbGbCtD
Glipizide—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.0129	0.0503	CbGbCtD
Glipizide—CYP3A4—Prednisone—systemic lupus erythematosus	0.0128	0.0501	CbGbCtD
Glipizide—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.0122	0.0475	CbGbCtD
Glipizide—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.008	0.0313	CbGbCtD
Glipizide—PPARG—endothelium—systemic lupus erythematosus	0.00296	0.0642	CbGeAlD
Glipizide—CYP2C9—urine—systemic lupus erythematosus	0.00295	0.0639	CbGeAlD
Glipizide—PPARG—blood plasma—systemic lupus erythematosus	0.00263	0.057	CbGeAlD
Glipizide—CYP3A4—urine—systemic lupus erythematosus	0.00225	0.0488	CbGeAlD
Glipizide—ABCC8—kidney—systemic lupus erythematosus	0.00156	0.0338	CbGeAlD
Glipizide—CYP2C9—blood plasma—systemic lupus erythematosus	0.00154	0.0334	CbGeAlD
Glipizide—Gliclazide—VEGFA—systemic lupus erythematosus	0.00146	0.709	CrCbGaD
Glipizide—KCNJ11—lymphoid tissue—systemic lupus erythematosus	0.00145	0.0316	CbGeAlD
Glipizide—PPARG—connective tissue—systemic lupus erythematosus	0.0014	0.0303	CbGeAlD
Glipizide—KCNJ11—tendon—systemic lupus erythematosus	0.00137	0.0297	CbGeAlD
Glipizide—PPARG—skin of body—systemic lupus erythematosus	0.00126	0.0274	CbGeAlD
Glipizide—PPARG—kidney—systemic lupus erythematosus	0.00119	0.0258	CbGeAlD
Glipizide—CYP3A4—blood plasma—systemic lupus erythematosus	0.00117	0.0254	CbGeAlD
Glipizide—KCNJ11—nervous system—systemic lupus erythematosus	0.00111	0.0241	CbGeAlD
Glipizide—KCNJ11—central nervous system—systemic lupus erythematosus	0.00107	0.0232	CbGeAlD
Glipizide—ABCC8—nervous system—systemic lupus erythematosus	0.00102	0.0222	CbGeAlD
Glipizide—PPARG—lymphoid tissue—systemic lupus erythematosus	0.00102	0.0222	CbGeAlD
Glipizide—ABCC8—central nervous system—systemic lupus erythematosus	0.000986	0.0214	CbGeAlD
Glipizide—PPARG—tendon—systemic lupus erythematosus	0.000962	0.0209	CbGeAlD
Glipizide—PPARG—bone marrow—systemic lupus erythematosus	0.000931	0.0202	CbGeAlD
Glipizide—PPARG—lung—systemic lupus erythematosus	0.000844	0.0183	CbGeAlD
Glipizide—PPARG—nervous system—systemic lupus erythematosus	0.000781	0.0169	CbGeAlD
Glipizide—PPARG—central nervous system—systemic lupus erythematosus	0.000752	0.0163	CbGeAlD
Glipizide—CYP3A4—kidney—systemic lupus erythematosus	0.000532	0.0115	CbGeAlD
Glipizide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IKZF1—systemic lupus erythematosus	0.000399	0.0479	CbGpPWpGaD
Glipizide—Gliclazide—ALB—systemic lupus erythematosus	0.000393	0.191	CrCbGaD
Glipizide—KCNJ11—Type II diabetes mellitus—ADIPOQ—systemic lupus erythematosus	0.000373	0.0448	CbGpPWpGaD
Glipizide—CYP3A4—nervous system—systemic lupus erythematosus	0.000349	0.00757	CbGeAlD
Glipizide—CYP3A4—central nervous system—systemic lupus erythematosus	0.000336	0.00729	CbGeAlD
Glipizide—PPARG—Signaling events mediated by HDAC Class I—MTA2—systemic lupus erythematosus	0.000291	0.0349	CbGpPWpGaD
Glipizide—PPARG—Transcription factor regulation in adipogenesis—ADIPOQ—systemic lupus erythematosus	0.000276	0.0331	CbGpPWpGaD
Glipizide—PPARG—Differentiation of white and brown adipocyte   —ADIPOQ—systemic lupus erythematosus	0.000249	0.0299	CbGpPWpGaD
Glipizide—PPARG—Transcription factor regulation in adipogenesis—RXRA—systemic lupus erythematosus	0.000236	0.0284	CbGpPWpGaD
Glipizide—PPARG—RXR and RAR heterodimerization with other nuclear receptor—RXRA—systemic lupus erythematosus	0.000207	0.0248	CbGpPWpGaD
Glipizide—Glyburide—ALB—systemic lupus erythematosus	0.000206	0.1	CrCbGaD
Glipizide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—systemic lupus erythematosus	0.000202	0.0242	CbGpPWpGaD
Glipizide—PPARG—Transcription factor regulation in adipogenesis—NR3C1—systemic lupus erythematosus	0.000192	0.0231	CbGpPWpGaD
Glipizide—PPARG—RXR and RAR heterodimerization with other nuclear receptor—VDR—systemic lupus erythematosus	0.000187	0.0225	CbGpPWpGaD
Glipizide—Syncope—Betamethasone—systemic lupus erythematosus	0.00016	0.0013	CcSEcCtD
Glipizide—Syncope—Dexamethasone—systemic lupus erythematosus	0.00016	0.0013	CcSEcCtD
Glipizide—Pain—Mycophenolate mofetil—systemic lupus erythematosus	0.00016	0.0013	CcSEcCtD
Glipizide—Constipation—Mycophenolate mofetil—systemic lupus erythematosus	0.00016	0.0013	CcSEcCtD
Glipizide—Arrhythmia—Prednisone—systemic lupus erythematosus	0.000159	0.0013	CcSEcCtD
Glipizide—Sweating—Methotrexate—systemic lupus erythematosus	0.000159	0.0013	CcSEcCtD
Glipizide—Feeling abnormal—Cyclosporine—systemic lupus erythematosus	0.000158	0.00129	CcSEcCtD
Glipizide—Vomiting—Leflunomide—systemic lupus erythematosus	0.000158	0.00129	CcSEcCtD
Glipizide—Shock—Triamcinolone—systemic lupus erythematosus	0.000158	0.00128	CcSEcCtD
Glipizide—Insomnia—Prednisolone—systemic lupus erythematosus	0.000158	0.00128	CcSEcCtD
Glipizide—Shock—Methylprednisolone—systemic lupus erythematosus	0.000158	0.00128	CcSEcCtD
Glipizide—Hepatobiliary disease—Methotrexate—systemic lupus erythematosus	0.000157	0.00128	CcSEcCtD
Glipizide—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	0.000157	0.00128	CcSEcCtD
Glipizide—Loss of consciousness—Dexamethasone—systemic lupus erythematosus	0.000157	0.00128	CcSEcCtD
Glipizide—Loss of consciousness—Betamethasone—systemic lupus erythematosus	0.000157	0.00128	CcSEcCtD
Glipizide—Paraesthesia—Prednisolone—systemic lupus erythematosus	0.000157	0.00127	CcSEcCtD
Glipizide—Rash—Leflunomide—systemic lupus erythematosus	0.000157	0.00127	CcSEcCtD
Glipizide—Dermatitis—Leflunomide—systemic lupus erythematosus	0.000157	0.00127	CcSEcCtD
Glipizide—Nausea—Azathioprine—systemic lupus erythematosus	0.000156	0.00127	CcSEcCtD
Glipizide—Headache—Leflunomide—systemic lupus erythematosus	0.000156	0.00127	CcSEcCtD
Glipizide—Erythema—Prednisone—systemic lupus erythematosus	0.000155	0.00126	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	0.000155	0.00126	CcSEcCtD
Glipizide—Hyperhidrosis—Triamcinolone—systemic lupus erythematosus	0.000155	0.00126	CcSEcCtD
Glipizide—Agranulocytosis—Methotrexate—systemic lupus erythematosus	0.000155	0.00126	CcSEcCtD
Glipizide—Hyperhidrosis—Methylprednisolone—systemic lupus erythematosus	0.000155	0.00126	CcSEcCtD
Glipizide—ABCC8—FOXA2 and FOXA3 transcription factor networks—NR3C1—systemic lupus erythematosus	0.000154	0.0185	CbGpPWpGaD
Glipizide—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	0.000154	0.00125	CcSEcCtD
Glipizide—Insomnia—Hydrocortisone—systemic lupus erythematosus	0.000154	0.00125	CcSEcCtD
Glipizide—Hypertension—Betamethasone—systemic lupus erythematosus	0.000154	0.00125	CcSEcCtD
Glipizide—Hypertension—Dexamethasone—systemic lupus erythematosus	0.000154	0.00125	CcSEcCtD
Glipizide—Paraesthesia—Hydrocortisone—systemic lupus erythematosus	0.000153	0.00124	CcSEcCtD
Glipizide—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000153	0.00124	CcSEcCtD
Glipizide—PPARG—Nuclear Receptors—RXRA—systemic lupus erythematosus	0.000152	0.0183	CbGpPWpGaD
Glipizide—Urticaria—Cyclosporine—systemic lupus erythematosus	0.000152	0.00124	CcSEcCtD
Glipizide—Myalgia—Betamethasone—systemic lupus erythematosus	0.000152	0.00124	CcSEcCtD
Glipizide—Myalgia—Dexamethasone—systemic lupus erythematosus	0.000152	0.00124	CcSEcCtD
Glipizide—Abdominal pain—Cyclosporine—systemic lupus erythematosus	0.000152	0.00123	CcSEcCtD
Glipizide—Anxiety—Betamethasone—systemic lupus erythematosus	0.000151	0.00123	CcSEcCtD
Glipizide—Anxiety—Dexamethasone—systemic lupus erythematosus	0.000151	0.00123	CcSEcCtD
Glipizide—PPARG—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.000151	0.0181	CbGpPWpGaD
Glipizide—Discomfort—Betamethasone—systemic lupus erythematosus	0.00015	0.00122	CcSEcCtD
Glipizide—Discomfort—Dexamethasone—systemic lupus erythematosus	0.00015	0.00122	CcSEcCtD
Glipizide—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	0.00015	0.00122	CcSEcCtD
Glipizide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—NR3C1—systemic lupus erythematosus	0.00015	0.018	CbGpPWpGaD
Glipizide—Pain—Prednisolone—systemic lupus erythematosus	0.000149	0.00121	CcSEcCtD
Glipizide—Hepatitis—Methotrexate—systemic lupus erythematosus	0.000149	0.00121	CcSEcCtD
Glipizide—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	0.000149	0.00121	CcSEcCtD
Glipizide—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	0.000148	0.00121	CcSEcCtD
Glipizide—Pharyngitis—Methotrexate—systemic lupus erythematosus	0.000148	0.0012	CcSEcCtD
Glipizide—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000148	0.0012	CcSEcCtD
Glipizide—Nausea—Leflunomide—systemic lupus erythematosus	0.000148	0.0012	CcSEcCtD
Glipizide—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000147	0.0012	CcSEcCtD
Glipizide—Vision blurred—Prednisone—systemic lupus erythematosus	0.000146	0.00119	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	0.000146	0.00119	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	0.000146	0.00119	CcSEcCtD
Glipizide—Pain—Hydrocortisone—systemic lupus erythematosus	0.000146	0.00119	CcSEcCtD
Glipizide—Oedema—Dexamethasone—systemic lupus erythematosus	0.000146	0.00118	CcSEcCtD
Glipizide—Oedema—Betamethasone—systemic lupus erythematosus	0.000146	0.00118	CcSEcCtD
Glipizide—Insomnia—Triamcinolone—systemic lupus erythematosus	0.000145	0.00118	CcSEcCtD
Glipizide—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.000145	0.00118	CcSEcCtD
Glipizide—Ill-defined disorder—Prednisone—systemic lupus erythematosus	0.000144	0.00117	CcSEcCtD
Glipizide—Paraesthesia—Triamcinolone—systemic lupus erythematosus	0.000144	0.00117	CcSEcCtD
Glipizide—Feeling abnormal—Prednisolone—systemic lupus erythematosus	0.000144	0.00117	CcSEcCtD
Glipizide—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	0.000144	0.00117	CcSEcCtD
Glipizide—Visual impairment—Methotrexate—systemic lupus erythematosus	0.000144	0.00117	CcSEcCtD
Glipizide—Shock—Dexamethasone—systemic lupus erythematosus	0.000143	0.00117	CcSEcCtD
Glipizide—Shock—Betamethasone—systemic lupus erythematosus	0.000143	0.00117	CcSEcCtD
Glipizide—Dyspnoea—Triamcinolone—systemic lupus erythematosus	0.000143	0.00116	CcSEcCtD
Glipizide—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	0.000143	0.00116	CcSEcCtD
Glipizide—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	0.000143	0.00116	CcSEcCtD
Glipizide—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.000141	0.00115	CcSEcCtD
Glipizide—Dyspepsia—Triamcinolone—systemic lupus erythematosus	0.000141	0.00115	CcSEcCtD
Glipizide—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	0.000141	0.00115	CcSEcCtD
Glipizide—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	0.000141	0.00115	CcSEcCtD
Glipizide—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	0.000141	0.00115	CcSEcCtD
Glipizide—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	0.00014	0.00114	CcSEcCtD
Glipizide—Malaise—Prednisone—systemic lupus erythematosus	0.00014	0.00114	CcSEcCtD
Glipizide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUNB—systemic lupus erythematosus	0.00014	0.0168	CbGpPWpGaD
Glipizide—Vertigo—Prednisone—systemic lupus erythematosus	0.00014	0.00114	CcSEcCtD
Glipizide—Eye disorder—Methotrexate—systemic lupus erythematosus	0.000139	0.00113	CcSEcCtD
Glipizide—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	0.000139	0.00113	CcSEcCtD
Glipizide—Syncope—Prednisone—systemic lupus erythematosus	0.000139	0.00113	CcSEcCtD
Glipizide—Anorexia—Betamethasone—systemic lupus erythematosus	0.000139	0.00113	CcSEcCtD
Glipizide—Anorexia—Dexamethasone—systemic lupus erythematosus	0.000139	0.00113	CcSEcCtD
Glipizide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—systemic lupus erythematosus	0.000139	0.0167	CbGpPWpGaD
Glipizide—Urticaria—Prednisolone—systemic lupus erythematosus	0.000139	0.00113	CcSEcCtD
Glipizide—PPARG—Nuclear Receptors—VDR—systemic lupus erythematosus	0.000138	0.0166	CbGpPWpGaD
Glipizide—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.000138	0.00112	CcSEcCtD
Glipizide—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000138	0.00112	CcSEcCtD
Glipizide—Pain—Triamcinolone—systemic lupus erythematosus	0.000137	0.00112	CcSEcCtD
Glipizide—Loss of consciousness—Prednisone—systemic lupus erythematosus	0.000137	0.00111	CcSEcCtD
Glipizide—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000136	0.0011	CcSEcCtD
Glipizide—Urticaria—Hydrocortisone—systemic lupus erythematosus	0.000135	0.0011	CcSEcCtD
Glipizide—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	0.000135	0.0011	CcSEcCtD
Glipizide—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000134	0.00109	CcSEcCtD
Glipizide—Hypertension—Prednisone—systemic lupus erythematosus	0.000134	0.00109	CcSEcCtD
Glipizide—Chills—Methotrexate—systemic lupus erythematosus	0.000134	0.00109	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	0.000133	0.00108	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	0.000133	0.00108	CcSEcCtD
Glipizide—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.000132	0.00108	CcSEcCtD
Glipizide—Myalgia—Prednisone—systemic lupus erythematosus	0.000132	0.00108	CcSEcCtD
Glipizide—Arthralgia—Prednisone—systemic lupus erythematosus	0.000132	0.00108	CcSEcCtD
Glipizide—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	0.000132	0.00108	CcSEcCtD
Glipizide—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	0.000132	0.00107	CcSEcCtD
Glipizide—Anxiety—Prednisone—systemic lupus erythematosus	0.000132	0.00107	CcSEcCtD
Glipizide—Insomnia—Betamethasone—systemic lupus erythematosus	0.000132	0.00107	CcSEcCtD
Glipizide—Insomnia—Dexamethasone—systemic lupus erythematosus	0.000132	0.00107	CcSEcCtD
Glipizide—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000131	0.00107	CcSEcCtD
Glipizide—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	0.000131	0.00107	CcSEcCtD
Glipizide—Paraesthesia—Betamethasone—systemic lupus erythematosus	0.000131	0.00106	CcSEcCtD
Glipizide—Paraesthesia—Dexamethasone—systemic lupus erythematosus	0.000131	0.00106	CcSEcCtD
Glipizide—Discomfort—Prednisone—systemic lupus erythematosus	0.000131	0.00106	CcSEcCtD
Glipizide—Erythema—Methotrexate—systemic lupus erythematosus	0.00013	0.00106	CcSEcCtD
Glipizide—ABCC8—FOXA2 and FOXA3 transcription factor networks—F2—systemic lupus erythematosus	0.000129	0.0155	CbGpPWpGaD
Glipizide—Hypersensitivity—Prednisolone—systemic lupus erythematosus	0.000129	0.00105	CcSEcCtD
Glipizide—Dyspepsia—Betamethasone—systemic lupus erythematosus	0.000128	0.00104	CcSEcCtD
Glipizide—Dyspepsia—Dexamethasone—systemic lupus erythematosus	0.000128	0.00104	CcSEcCtD
Glipizide—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000128	0.00104	CcSEcCtD
Glipizide—Urticaria—Triamcinolone—systemic lupus erythematosus	0.000128	0.00104	CcSEcCtD
Glipizide—Urticaria—Methylprednisolone—systemic lupus erythematosus	0.000127	0.00103	CcSEcCtD
Glipizide—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000127	0.00103	CcSEcCtD
Glipizide—Oedema—Prednisone—systemic lupus erythematosus	0.000127	0.00103	CcSEcCtD
Glipizide—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	0.000127	0.00103	CcSEcCtD
Glipizide—Decreased appetite—Dexamethasone—systemic lupus erythematosus	0.000127	0.00103	CcSEcCtD
Glipizide—Decreased appetite—Betamethasone—systemic lupus erythematosus	0.000127	0.00103	CcSEcCtD
Glipizide—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.000126	0.00102	CcSEcCtD
Glipizide—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.000126	0.00102	CcSEcCtD
Glipizide—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	0.000126	0.00102	CcSEcCtD
Glipizide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—F2—systemic lupus erythematosus	0.000125	0.0151	CbGpPWpGaD
Glipizide—Shock—Prednisone—systemic lupus erythematosus	0.000125	0.00101	CcSEcCtD
Glipizide—Pain—Dexamethasone—systemic lupus erythematosus	0.000125	0.00101	CcSEcCtD
Glipizide—Pain—Betamethasone—systemic lupus erythematosus	0.000125	0.00101	CcSEcCtD
Glipizide—PPARG—Nuclear Receptors—NR3C1—systemic lupus erythematosus	0.000124	0.0149	CbGpPWpGaD
Glipizide—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.000124	0.00101	CcSEcCtD
Glipizide—Hyperhidrosis—Prednisone—systemic lupus erythematosus	0.000123	0.000997	CcSEcCtD
Glipizide—Vision blurred—Methotrexate—systemic lupus erythematosus	0.000122	0.000995	CcSEcCtD
Glipizide—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000122	0.000995	CcSEcCtD
Glipizide—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000122	0.000992	CcSEcCtD
Glipizide—Rash—Cyclosporine—systemic lupus erythematosus	0.000121	0.000984	CcSEcCtD
Glipizide—Anorexia—Prednisone—systemic lupus erythematosus	0.000121	0.000983	CcSEcCtD
Glipizide—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000121	0.000983	CcSEcCtD
Glipizide—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000121	0.000981	CcSEcCtD
Glipizide—PPARG—Nuclear Receptor transcription pathway—RXRA—systemic lupus erythematosus	0.000121	0.0145	CbGpPWpGaD
Glipizide—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	0.00012	0.00098	CcSEcCtD
Glipizide—Headache—Cyclosporine—systemic lupus erythematosus	0.00012	0.000977	CcSEcCtD
Glipizide—Feeling abnormal—Betamethasone—systemic lupus erythematosus	0.00012	0.000976	CcSEcCtD
Glipizide—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	0.00012	0.000976	CcSEcCtD
Glipizide—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	0.000119	0.000969	CcSEcCtD
Glipizide—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	0.000119	0.000969	CcSEcCtD
Glipizide—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000119	0.000968	CcSEcCtD
Glipizide—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	0.000118	0.000962	CcSEcCtD
Glipizide—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	0.000118	0.00096	CcSEcCtD
Glipizide—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.000118	0.000959	CcSEcCtD
Glipizide—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000118	0.000959	CcSEcCtD
Glipizide—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000117	0.000953	CcSEcCtD
Glipizide—Malaise—Methotrexate—systemic lupus erythematosus	0.000117	0.000953	CcSEcCtD
Glipizide—Vertigo—Methotrexate—systemic lupus erythematosus	0.000117	0.000949	CcSEcCtD
Glipizide—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000117	0.000949	CcSEcCtD
Glipizide—Leukopenia—Methotrexate—systemic lupus erythematosus	0.000116	0.000945	CcSEcCtD
Glipizide—Urticaria—Dexamethasone—systemic lupus erythematosus	0.000116	0.000941	CcSEcCtD
Glipizide—Urticaria—Betamethasone—systemic lupus erythematosus	0.000116	0.000941	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	0.000116	0.00094	CcSEcCtD
Glipizide—Dizziness—Prednisolone—systemic lupus erythematosus	0.000115	0.000939	CcSEcCtD
Glipizide—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000115	0.000937	CcSEcCtD
Glipizide—Abdominal pain—Dexamethasone—systemic lupus erythematosus	0.000115	0.000936	CcSEcCtD
Glipizide—Abdominal pain—Betamethasone—systemic lupus erythematosus	0.000115	0.000936	CcSEcCtD
Glipizide—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.000115	0.000934	CcSEcCtD
Glipizide—Insomnia—Prednisone—systemic lupus erythematosus	0.000115	0.000933	CcSEcCtD
Glipizide—Nausea—Cyclosporine—systemic lupus erythematosus	0.000114	0.000927	CcSEcCtD
Glipizide—Paraesthesia—Prednisone—systemic lupus erythematosus	0.000114	0.000926	CcSEcCtD
Glipizide—Pruritus—Triamcinolone—systemic lupus erythematosus	0.000114	0.000924	CcSEcCtD
Glipizide—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.000113	0.000921	CcSEcCtD
Glipizide—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000113	0.000917	CcSEcCtD
Glipizide—Dyspepsia—Prednisone—systemic lupus erythematosus	0.000112	0.000908	CcSEcCtD
Glipizide—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000111	0.000904	CcSEcCtD
Glipizide—Myalgia—Methotrexate—systemic lupus erythematosus	0.000111	0.000899	CcSEcCtD
Glipizide—Arthralgia—Methotrexate—systemic lupus erythematosus	0.000111	0.000899	CcSEcCtD
Glipizide—Decreased appetite—Prednisone—systemic lupus erythematosus	0.00011	0.000897	CcSEcCtD
Glipizide—Rash—Prednisolone—systemic lupus erythematosus	0.00011	0.000895	CcSEcCtD
Glipizide—Dermatitis—Prednisolone—systemic lupus erythematosus	0.00011	0.000894	CcSEcCtD
Glipizide—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.00011	0.000891	CcSEcCtD
Glipizide—Headache—Prednisolone—systemic lupus erythematosus	0.000109	0.000889	CcSEcCtD
Glipizide—Discomfort—Methotrexate—systemic lupus erythematosus	0.000109	0.000888	CcSEcCtD
Glipizide—PPARG—Nuclear Receptor transcription pathway—VDR—systemic lupus erythematosus	0.000109	0.0131	CbGpPWpGaD
Glipizide—Constipation—Prednisone—systemic lupus erythematosus	0.000108	0.000882	CcSEcCtD
Glipizide—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.000108	0.000881	CcSEcCtD
Glipizide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—systemic lupus erythematosus	0.000108	0.013	CbGpPWpGaD
Glipizide—CYP3A4—Liver X Receptor Pathway—RXRA—systemic lupus erythematosus	0.000108	0.013	CbGpPWpGaD
Glipizide—Rash—Hydrocortisone—systemic lupus erythematosus	0.000107	0.000874	CcSEcCtD
Glipizide—ABCC8—FOXA2 and FOXA3 transcription factor networks—ALB—systemic lupus erythematosus	0.000107	0.0129	CbGpPWpGaD
Glipizide—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.000107	0.000873	CcSEcCtD
Glipizide—KCNJ11—Type II diabetes mellitus—TNF—systemic lupus erythematosus	0.000107	0.0129	CbGpPWpGaD
Glipizide—Confusional state—Methotrexate—systemic lupus erythematosus	0.000107	0.000869	CcSEcCtD
Glipizide—Headache—Hydrocortisone—systemic lupus erythematosus	0.000107	0.000868	CcSEcCtD
Glipizide—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000106	0.000863	CcSEcCtD
Glipizide—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000106	0.000861	CcSEcCtD
Glipizide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—systemic lupus erythematosus	0.000105	0.0126	CbGpPWpGaD
Glipizide—Feeling abnormal—Prednisone—systemic lupus erythematosus	0.000105	0.00085	CcSEcCtD
Glipizide—Asthenia—Dexamethasone—systemic lupus erythematosus	0.000104	0.00085	CcSEcCtD
Glipizide—Asthenia—Betamethasone—systemic lupus erythematosus	0.000104	0.00085	CcSEcCtD
Glipizide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—ALB—systemic lupus erythematosus	0.000104	0.0125	CbGpPWpGaD
Glipizide—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	0.000104	0.000844	CcSEcCtD
Glipizide—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	0.000104	0.000843	CcSEcCtD
Glipizide—Nausea—Prednisolone—systemic lupus erythematosus	0.000104	0.000843	CcSEcCtD
Glipizide—Pruritus—Dexamethasone—systemic lupus erythematosus	0.000103	0.000838	CcSEcCtD
Glipizide—Pruritus—Betamethasone—systemic lupus erythematosus	0.000103	0.000838	CcSEcCtD
Glipizide—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	0.000102	0.000833	CcSEcCtD
Glipizide—Vomiting—Triamcinolone—systemic lupus erythematosus	0.000102	0.00083	CcSEcCtD
Glipizide—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.000102	0.000828	CcSEcCtD
Glipizide—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000101	0.000823	CcSEcCtD
Glipizide—Rash—Triamcinolone—systemic lupus erythematosus	0.000101	0.000823	CcSEcCtD
Glipizide—PPARG—Transcriptional regulation of white adipocyte differentiation—ADIPOQ—systemic lupus erythematosus	0.000101	0.0122	CbGpPWpGaD
Glipizide—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.000101	0.000822	CcSEcCtD
Glipizide—Anorexia—Methotrexate—systemic lupus erythematosus	0.000101	0.000822	CcSEcCtD
Glipizide—Rash—Methylprednisolone—systemic lupus erythematosus	0.000101	0.000821	CcSEcCtD
Glipizide—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.000101	0.00082	CcSEcCtD
Glipizide—Urticaria—Prednisone—systemic lupus erythematosus	0.000101	0.000819	CcSEcCtD
Glipizide—Headache—Triamcinolone—systemic lupus erythematosus	0.000101	0.000818	CcSEcCtD
Glipizide—Headache—Methylprednisolone—systemic lupus erythematosus	0.0001	0.000816	CcSEcCtD
Glipizide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—systemic lupus erythematosus	0.0001	0.0121	CbGpPWpGaD
Glipizide—Abdominal pain—Prednisone—systemic lupus erythematosus	0.0001	0.000815	CcSEcCtD
Glipizide—Diarrhoea—Dexamethasone—systemic lupus erythematosus	9.96e-05	0.00081	CcSEcCtD
Glipizide—Diarrhoea—Betamethasone—systemic lupus erythematosus	9.96e-05	0.00081	CcSEcCtD
Glipizide—PPARG—Nuclear Receptor transcription pathway—NR3C1—systemic lupus erythematosus	9.82e-05	0.0118	CbGpPWpGaD
Glipizide—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	9.66e-05	0.000785	CcSEcCtD
Glipizide—Dizziness—Betamethasone—systemic lupus erythematosus	9.63e-05	0.000783	CcSEcCtD
Glipizide—Dizziness—Dexamethasone—systemic lupus erythematosus	9.63e-05	0.000783	CcSEcCtD
Glipizide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—systemic lupus erythematosus	9.61e-05	0.0116	CbGpPWpGaD
Glipizide—Insomnia—Methotrexate—systemic lupus erythematosus	9.59e-05	0.00078	CcSEcCtD
Glipizide—Nausea—Triamcinolone—systemic lupus erythematosus	9.53e-05	0.000775	CcSEcCtD
Glipizide—Paraesthesia—Methotrexate—systemic lupus erythematosus	9.52e-05	0.000774	CcSEcCtD
Glipizide—Nausea—Methylprednisolone—systemic lupus erythematosus	9.51e-05	0.000774	CcSEcCtD
Glipizide—Dyspnoea—Methotrexate—systemic lupus erythematosus	9.45e-05	0.000769	CcSEcCtD
Glipizide—Somnolence—Methotrexate—systemic lupus erythematosus	9.42e-05	0.000766	CcSEcCtD
Glipizide—Hypersensitivity—Prednisone—systemic lupus erythematosus	9.34e-05	0.00076	CcSEcCtD
Glipizide—Dyspepsia—Methotrexate—systemic lupus erythematosus	9.33e-05	0.000759	CcSEcCtD
Glipizide—Vomiting—Dexamethasone—systemic lupus erythematosus	9.26e-05	0.000753	CcSEcCtD
Glipizide—Vomiting—Betamethasone—systemic lupus erythematosus	9.26e-05	0.000753	CcSEcCtD
Glipizide—Decreased appetite—Methotrexate—systemic lupus erythematosus	9.21e-05	0.000749	CcSEcCtD
Glipizide—Rash—Dexamethasone—systemic lupus erythematosus	9.18e-05	0.000747	CcSEcCtD
Glipizide—Rash—Betamethasone—systemic lupus erythematosus	9.18e-05	0.000747	CcSEcCtD
Glipizide—Dermatitis—Betamethasone—systemic lupus erythematosus	9.17e-05	0.000746	CcSEcCtD
Glipizide—Dermatitis—Dexamethasone—systemic lupus erythematosus	9.17e-05	0.000746	CcSEcCtD
Glipizide—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	9.15e-05	0.000744	CcSEcCtD
Glipizide—Headache—Betamethasone—systemic lupus erythematosus	9.12e-05	0.000742	CcSEcCtD
Glipizide—Headache—Dexamethasone—systemic lupus erythematosus	9.12e-05	0.000742	CcSEcCtD
Glipizide—ABCC8—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	9.12e-05	0.011	CbGpPWpGaD
Glipizide—Asthenia—Prednisone—systemic lupus erythematosus	9.1e-05	0.00074	CcSEcCtD
Glipizide—Pain—Methotrexate—systemic lupus erythematosus	9.06e-05	0.000737	CcSEcCtD
Glipizide—Pruritus—Prednisone—systemic lupus erythematosus	8.97e-05	0.00073	CcSEcCtD
Glipizide—Feeling abnormal—Methotrexate—systemic lupus erythematosus	8.73e-05	0.00071	CcSEcCtD
Glipizide—Diarrhoea—Prednisone—systemic lupus erythematosus	8.68e-05	0.000706	CcSEcCtD
Glipizide—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	8.67e-05	0.000705	CcSEcCtD
Glipizide—PPARG—Transcriptional regulation of white adipocyte differentiation—RXRA—systemic lupus erythematosus	8.67e-05	0.0104	CbGpPWpGaD
Glipizide—Nausea—Dexamethasone—systemic lupus erythematosus	8.65e-05	0.000704	CcSEcCtD
Glipizide—Nausea—Betamethasone—systemic lupus erythematosus	8.65e-05	0.000704	CcSEcCtD
Glipizide—Urticaria—Methotrexate—systemic lupus erythematosus	8.42e-05	0.000685	CcSEcCtD
Glipizide—Dizziness—Prednisone—systemic lupus erythematosus	8.39e-05	0.000682	CcSEcCtD
Glipizide—Abdominal pain—Methotrexate—systemic lupus erythematosus	8.38e-05	0.000681	CcSEcCtD
Glipizide—Vomiting—Prednisone—systemic lupus erythematosus	8.06e-05	0.000656	CcSEcCtD
Glipizide—Rash—Prednisone—systemic lupus erythematosus	8e-05	0.00065	CcSEcCtD
Glipizide—Dermatitis—Prednisone—systemic lupus erythematosus	7.99e-05	0.00065	CcSEcCtD
Glipizide—Headache—Prednisone—systemic lupus erythematosus	7.95e-05	0.000646	CcSEcCtD
Glipizide—PPARG—Transcription factor regulation in adipogenesis—TNF—systemic lupus erythematosus	7.92e-05	0.00952	CbGpPWpGaD
Glipizide—Hypersensitivity—Methotrexate—systemic lupus erythematosus	7.81e-05	0.000635	CcSEcCtD
Glipizide—Asthenia—Methotrexate—systemic lupus erythematosus	7.6e-05	0.000619	CcSEcCtD
Glipizide—Nausea—Prednisone—systemic lupus erythematosus	7.53e-05	0.000613	CcSEcCtD
Glipizide—Pruritus—Methotrexate—systemic lupus erythematosus	7.5e-05	0.00061	CcSEcCtD
Glipizide—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—systemic lupus erythematosus	7.42e-05	0.00892	CbGpPWpGaD
Glipizide—Diarrhoea—Methotrexate—systemic lupus erythematosus	7.25e-05	0.00059	CcSEcCtD
Glipizide—Dizziness—Methotrexate—systemic lupus erythematosus	7.01e-05	0.00057	CcSEcCtD
Glipizide—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—systemic lupus erythematosus	6.93e-05	0.00833	CbGpPWpGaD
Glipizide—PPARG—Adipogenesis—GADD45A—systemic lupus erythematosus	6.9e-05	0.00829	CbGpPWpGaD
Glipizide—Vomiting—Methotrexate—systemic lupus erythematosus	6.74e-05	0.000548	CcSEcCtD
Glipizide—Rash—Methotrexate—systemic lupus erythematosus	6.68e-05	0.000544	CcSEcCtD
Glipizide—Dermatitis—Methotrexate—systemic lupus erythematosus	6.68e-05	0.000543	CcSEcCtD
Glipizide—PPARG—Adipogenesis—ADIPOQ—systemic lupus erythematosus	6.65e-05	0.008	CbGpPWpGaD
Glipizide—Headache—Methotrexate—systemic lupus erythematosus	6.64e-05	0.00054	CcSEcCtD
Glipizide—PPARG—PPARA activates gene expression—RXRA—systemic lupus erythematosus	6.52e-05	0.00783	CbGpPWpGaD
Glipizide—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—systemic lupus erythematosus	6.45e-05	0.00775	CbGpPWpGaD
Glipizide—CYP2C9—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	6.44e-05	0.00774	CbGpPWpGaD
Glipizide—PPARG—Transcription factor regulation in adipogenesis—IL6—systemic lupus erythematosus	6.39e-05	0.00768	CbGpPWpGaD
Glipizide—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—systemic lupus erythematosus	6.38e-05	0.00767	CbGpPWpGaD
Glipizide—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—RXRA—systemic lupus erythematosus	6.38e-05	0.00767	CbGpPWpGaD
Glipizide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—systemic lupus erythematosus	6.34e-05	0.00762	CbGpPWpGaD
Glipizide—Nausea—Methotrexate—systemic lupus erythematosus	6.3e-05	0.000512	CcSEcCtD
Glipizide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—systemic lupus erythematosus	6.08e-05	0.00731	CbGpPWpGaD
Glipizide—PPARG—Adipogenesis—RXRA—systemic lupus erythematosus	5.7e-05	0.00685	CbGpPWpGaD
Glipizide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—systemic lupus erythematosus	5.64e-05	0.00677	CbGpPWpGaD
Glipizide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	5.56e-05	0.00668	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—ADIPOQ—systemic lupus erythematosus	4.69e-05	0.00564	CbGpPWpGaD
Glipizide—PPARG—Adipogenesis—NR3C1—systemic lupus erythematosus	4.65e-05	0.00559	CbGpPWpGaD
Glipizide—PPARG—Regulation of retinoblastoma protein—CDKN1B—systemic lupus erythematosus	4.61e-05	0.00554	CbGpPWpGaD
Glipizide—PPARG—Adipogenesis—FAS—systemic lupus erythematosus	4.5e-05	0.00541	CbGpPWpGaD
Glipizide—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—systemic lupus erythematosus	4.39e-05	0.00528	CbGpPWpGaD
Glipizide—PPARG—Regulation of retinoblastoma protein—CDKN1A—systemic lupus erythematosus	4.26e-05	0.00512	CbGpPWpGaD
Glipizide—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	4.25e-05	0.00511	CbGpPWpGaD
Glipizide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—systemic lupus erythematosus	4.11e-05	0.00493	CbGpPWpGaD
Glipizide—PPARG—Regulation of retinoblastoma protein—EP300—systemic lupus erythematosus	4.05e-05	0.00487	CbGpPWpGaD
Glipizide—CYP2C9—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	3.9e-05	0.00468	CbGpPWpGaD
Glipizide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	3.88e-05	0.00466	CbGpPWpGaD
Glipizide—PPARG—Signaling events mediated by HDAC Class I—EP300—systemic lupus erythematosus	3.86e-05	0.00464	CbGpPWpGaD
Glipizide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	3.67e-05	0.00441	CbGpPWpGaD
Glipizide—PPARG—Transcriptional regulation of white adipocyte differentiation—EP300—systemic lupus erythematosus	3.58e-05	0.0043	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—SNRPD1—systemic lupus erythematosus	3.44e-05	0.00414	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—FAS—systemic lupus erythematosus	3.18e-05	0.00382	CbGpPWpGaD
Glipizide—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	3.16e-05	0.0038	CbGpPWpGaD
Glipizide—PPARG—Signaling events mediated by HDAC Class I—TNF—systemic lupus erythematosus	3.14e-05	0.00377	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—MTA2—systemic lupus erythematosus	3.11e-05	0.00374	CbGpPWpGaD
Glipizide—PPARG—Transcriptional regulation of white adipocyte differentiation—TGFB1—systemic lupus erythematosus	3.11e-05	0.00374	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—NAT2—systemic lupus erythematosus	2.99e-05	0.0036	CbGpPWpGaD
Glipizide—CYP2C9—Metapathway biotransformation—NAT2—systemic lupus erythematosus	2.95e-05	0.00355	CbGpPWpGaD
Glipizide—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—systemic lupus erythematosus	2.91e-05	0.00349	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—LYN—systemic lupus erythematosus	2.83e-05	0.0034	CbGpPWpGaD
Glipizide—PPARG—PPARA activates gene expression—EP300—systemic lupus erythematosus	2.69e-05	0.00324	CbGpPWpGaD
Glipizide—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—systemic lupus erythematosus	2.63e-05	0.00317	CbGpPWpGaD
Glipizide—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	2.57e-05	0.00309	CbGpPWpGaD
Glipizide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	2.56e-05	0.00307	CbGpPWpGaD
Glipizide—PPARG—Adipogenesis—CDKN1A—systemic lupus erythematosus	2.47e-05	0.00297	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—PTPRC—systemic lupus erythematosus	2.42e-05	0.00291	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—JUNB—systemic lupus erythematosus	2.38e-05	0.00285	CbGpPWpGaD
Glipizide—ABCC8—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	2.32e-05	0.00279	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—ADIPOQ—systemic lupus erythematosus	2.29e-05	0.00275	CbGpPWpGaD
Glipizide—CYP2C9—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	2.24e-05	0.00269	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—TNFSF13—systemic lupus erythematosus	2.1e-05	0.00253	CbGpPWpGaD
Glipizide—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	2.08e-05	0.0025	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—RXRA—systemic lupus erythematosus	2.08e-05	0.0025	CbGpPWpGaD
Glipizide—PPARG—Adipogenesis—TGFB1—systemic lupus erythematosus	2.05e-05	0.00246	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—SNRPB—systemic lupus erythematosus	2.04e-05	0.00245	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—NAT2—systemic lupus erythematosus	1.97e-05	0.00237	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—RXRA—systemic lupus erythematosus	1.96e-05	0.00236	CbGpPWpGaD
Glipizide—CYP3A4—Metapathway biotransformation—NAT2—systemic lupus erythematosus	1.95e-05	0.00234	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—NAT2—systemic lupus erythematosus	1.94e-05	0.00233	CbGpPWpGaD
Glipizide—PPARG—Adipogenesis—TNF—systemic lupus erythematosus	1.91e-05	0.0023	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—VDR—systemic lupus erythematosus	1.89e-05	0.00227	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—NAT2—systemic lupus erythematosus	1.88e-05	0.00226	CbGpPWpGaD
Glipizide—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—systemic lupus erythematosus	1.82e-05	0.00218	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.75e-05	0.0021	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	1.7e-05	0.00204	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—RXRA—systemic lupus erythematosus	1.68e-05	0.00202	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—EP300—systemic lupus erythematosus	1.66e-05	0.002	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—JAK1—systemic lupus erythematosus	1.65e-05	0.00198	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—HIST2H2AC—systemic lupus erythematosus	1.64e-05	0.00197	CbGpPWpGaD
Glipizide—PPARG—Adipogenesis—IL6—systemic lupus erythematosus	1.54e-05	0.00185	CbGpPWpGaD
Glipizide—PPARG—Metabolism—NAT2—systemic lupus erythematosus	1.39e-05	0.00167	CbGpPWpGaD
Glipizide—ABCC8—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.32e-05	0.00158	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—JUNB—systemic lupus erythematosus	1.14e-05	0.00137	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—RXRA—systemic lupus erythematosus	1.11e-05	0.00133	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—IL6—systemic lupus erythematosus	1.09e-05	0.00131	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—RXRA—systemic lupus erythematosus	1.09e-05	0.00131	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—TYK2—systemic lupus erythematosus	1.08e-05	0.0013	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—RXRA—systemic lupus erythematosus	1.05e-05	0.00127	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—RXRA—systemic lupus erythematosus	1e-05	0.0012	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	9.93e-06	0.00119	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—VDR—systemic lupus erythematosus	9.08e-06	0.00109	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	8.69e-06	0.00104	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—MMP9—systemic lupus erythematosus	8.54e-06	0.00103	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—NR3C1—systemic lupus erythematosus	8.17e-06	0.000982	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—EP300—systemic lupus erythematosus	8.09e-06	0.000973	CbGpPWpGaD
Glipizide—PPARG—Metabolism—RXRA—systemic lupus erythematosus	7.79e-06	0.000937	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—VEGFA—systemic lupus erythematosus	7.67e-06	0.000921	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	7.23e-06	0.000869	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—TGFB1—systemic lupus erythematosus	7.04e-06	0.000846	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PPARG—systemic lupus erythematosus	6.87e-06	0.000825	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PPARG—systemic lupus erythematosus	6.66e-06	0.0008	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—TNF—systemic lupus erythematosus	6.57e-06	0.00079	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	6.44e-06	0.000775	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ALB—systemic lupus erythematosus	6.17e-06	0.000742	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ALB—systemic lupus erythematosus	5.99e-06	0.00072	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—NOS3—systemic lupus erythematosus	5.9e-06	0.00071	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—NOS3—systemic lupus erythematosus	5.73e-06	0.000688	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PTGS2—systemic lupus erythematosus	5.4e-06	0.000649	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—IL6—systemic lupus erythematosus	5.3e-06	0.000637	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PTGS2—systemic lupus erythematosus	5.24e-06	0.000629	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—NAT2—systemic lupus erythematosus	5.12e-06	0.000615	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—EP300—systemic lupus erythematosus	4.49e-06	0.00054	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ALB—systemic lupus erythematosus	4.42e-06	0.000532	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—EP300—systemic lupus erythematosus	4.36e-06	0.000524	CbGpPWpGaD
Glipizide—PPARG—Metabolism—NOS3—systemic lupus erythematosus	4.23e-06	0.000509	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	4.07e-06	0.000489	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PTGS2—systemic lupus erythematosus	3.87e-06	0.000465	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	3.66e-06	0.00044	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	3.38e-06	0.000406	CbGpPWpGaD
Glipizide—PPARG—Metabolism—EP300—systemic lupus erythematosus	3.22e-06	0.000387	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	3.2e-06	0.000385	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—RXRA—systemic lupus erythematosus	2.87e-06	0.000345	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.66e-06	0.00032	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	1.89e-06	0.000227	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PPARG—systemic lupus erythematosus	1.81e-06	0.000218	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ALB—systemic lupus erythematosus	1.63e-06	0.000196	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—NOS3—systemic lupus erythematosus	1.56e-06	0.000187	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PTGS2—systemic lupus erythematosus	1.43e-06	0.000171	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	1.19e-06	0.000144	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—EP300—systemic lupus erythematosus	1.19e-06	0.000142	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	1.07e-06	0.000129	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	1.03e-06	0.000124	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	9.4e-07	0.000113	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	7.82e-07	9.4e-05	CbGpPWpGaD
